NCT00060359 Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer Status COMPLETED Phase PHASE1
NCT00060255 High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors Status COMPLETED Phase PHASE2
NCT00059787 Erlotinib Plus Carboplatin and Paclitaxel in Ovarian Carcinoma Status COMPLETED Phase PHASE2
NCT00059618 PS-341 Plus Carboplatin in Platinum and Taxane Resistant Recurrent Ovarian Cancer, Primary Peritoneal Cancer, and Fallopian Tube Cancer Status COMPLETED Phase PHASE1
NCT00058461 Combination Chemotherapy and Rituximab in Treating Young Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia Status TERMINATED Phase PHASE2
NCT00055965 Hospitalization Rates of Patients With Non-Small Cell Lung Cancer Treated With Gemcitabine and Either Cisplatin or Carboplatin Status UNKNOWN Phase PHASE3
NCT00055887 Chemotherapy and Radiation Therapy With or Without Efaproxiral in Treating Patients With Stage III Non-Small Cell Lung Cancer Status WITHDRAWN Phase PHASE3
NCT00055835 S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium Status COMPLETED Phase PHASE2
NCT00054392 Combination Chemotherapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer Status WITHDRAWN Phase PHASE3
NCT00054210 Polyglutamate Paclitaxel Plus Carboplatin Compared With Paclitaxel Plus Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE3
NCT00053287 Fludarabine/Carboplatin/Topotecan w/Thalidomide for Relapsed/Refractory AML, CML and MDS Status COMPLETED Phase PHASE2
NCT00053118 Chemotherapy and Stem Cell Transplantation in Treating Children With Central Nervous System Cancer Status COMPLETED Phase PHASE1
NCT00052338 Bortezomib Plus Gemcitabine and Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE1
NCT00051506 ALIMTA(Pemetrexed)/Cisplatin and ALIMTA(Pemetrexed)/Carboplatin in Extensive Stage Small Cell Lung Cancer. Status COMPLETED Phase PHASE2
NCT00051493 ALIMTA Plus Carboplatin as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial. Status COMPLETED Phase PHASE2
NCT00049790 Safety and Efficacy Study of rhAngiostatin Administered in Combination With Paclitaxel and Carboplatin to Patients With Non-Small-Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00049257 Paclitaxel and Carboplatin in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy Status COMPLETED Phase PHASE2
NCT00049218 Chemotherapy Followed By Vaccine Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00047320 Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors Status COMPLETED Phase PHASE2
NCT00047255 Docetaxel and Trastuzumab With or Without Carboplatin in Treating Women With HER2-Positive Breast Cancer Status COMPLETED Phase PHASE3